EN DE
STOCK COMPARISON

JHS Svendgaard Laboratories vs Procter & Gamble: Fair Value & Quality

Both stocks run through our valuation models. Here is how JHS Svendgaard Laboratories (JHS) and Procter & Gamble (PG) compare, as of Aug 17, 2026.

As of Aug 17, 2026, Fair Value Calculator sees Procter & Gamble as the less overvalued of the two: JHS Svendgaard Laboratories trades at ₹8.95 versus a fair value of ₹4.38 (-51%), while Procter & Gamble trades at $145 versus $108 (-25%).
JHS Svendgaard Laboratories
JHS.NSE · INR · Consumer Staples
-51%
upside to fair value
overvalued
Price₹8.95
Fair Value₹4.38
Quality41/100
Procter & Gamble
PG · USD · Consumer Staples
-25%
upside to fair value
overvalued
Price$145
Fair Value$108
Quality75/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

JHS Svendgaard LaboratoriesProcter & Gamble
Valuation
P/E (TTM)21.5×
P/S (TTM)3.95×
P/B6.58×
EV/EBITDA14.3×
PEG4.13×
Dividend yield2.9%
Dividend per share$4.23
Profitability
-2%Net margin19%
-8%Operating margin23%
-1%Return on equity31%
-0%Return on assets11%
Growth
39%Revenue growth (YoY)7%
6.5%Avg. growth/yr (3Y)1.7%
0.3%Avg. growth/yr (5Y)3.5%
Balance & size
0.03×Debt / equity0.48×
$7MMarket cap$342B
weakGrowth qualityhealthy

Procter & Gamble leads: 3 to 5 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

JHS Svendgaard Laboratoriesof which business quality 41 · market factors 34 Procter & Gambleof which business quality 71 · market factors 52
ProfitabilityMargins and returns on capital today
15
73
Quality GrowthAre margins and returns improving?
62
46
CashflowEarnings quality: real cash, not paper profit
16
65
Fin. StrengthBalance sheet, leverage, solvency risk
59
70
InvestmentDisciplined investing over empire-building
80
85
Low VolatilityCalm price path (market factor)
55
95
MomentumPrice trend over the last 3–12 months (market factor)
26
37
52W MomentumDistance to the 52-week high (market factor)
22
29
Net IssuanceBuybacks instead of dilution
38
91

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

JHS Svendgaard Laboratories

Multiples₹5.44
Asset-Based₹13.39

1 of 2 models see the stock below the current price.

Procter & Gamble

DCF Models$97.73
Earnings-Based$85.21
Dividend Discount$59.55
Multiples$120
Asset-Based$14.97
Growth DCF$74.21
Economic Profit$68.20
Growth Earnings$112

24 of 24 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

JHS Svendgaard Laboratories
Bear ₹3.40Fair Value ₹4.38Bull ₹5.35
₹8.95 = current price (white tick)
Procter & Gamble
Bear $70.77Fair Value $108Bull $151
$145 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

JHS Svendgaard Laboratories · Consumer Staples

Quality score41 · bottom 25%
Fair value upside-51% · bottom 25%

Procter & Gamble · Consumer Staples

Quality score75 · Top 25%
Fair value upside-25% · below median

Bottom line

As of Aug 17, 2026, Fair Value Calculator sees Procter & Gamble as the less overvalued of the two: JHS Svendgaard Laboratories trades at ₹8.95 versus a fair value of ₹4.38 (-51%), while Procter & Gamble trades at $145 versus $108 (-25%).

Procter & Gamble has the higher quality score (75/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.